{
    "xml": "<topic id=\"PHP4497\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/norethisterone\" basename=\"norethisterone\" title=\"NORETHISTERONE\">\n<title>NORETHISTERONE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_673\" namespace=\"/interactions/list-of-drug-interactions/progestogens/norethisterone\">Norethisterone</xref>\n</p>\n<data name=\"vtmid\">63758001</data>\r\n<data name=\"vtmid\">13964211000001102</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_203813864\" title=\"Progestogens\">Progestogens</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">   </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP63662\" outputclass=\"indicationsAndDose\" rev=\"1.34\" parent=\"/drugs/norethisterone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Endometriosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;15&#8239;mg daily for 4&#8211;6 months or longer, to be started on day 5 of cycle; increased to 20&#8211;25&#8239;mg daily if required, dose only increased if spotting occurs and reduced once bleeding has stopped.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Dysfunctional uterine bleeding (to arrest bleeding)</p>\n<p outputclass=\"therapeuticIndication\">Menorrhagia (to arrest bleeding)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg 3 times a day for 10 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Dysfunctional uterine bleeding (to prevent bleeding)</p>\n<p outputclass=\"therapeuticIndication\">Menorrhagia (to prevent bleeding)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg twice daily, to be taken from day 19 to day 26 of cycle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Dysmenorrhoea</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg 3 times a day for 3&#8211;4 cycles, to be taken from day 5&#8211;24 of cycle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Premenstrual syndrome (but not recommended)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg 2&#8211;3 times a day for several cycles, to be taken from day 19&#8211;26 of cycle.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Postponement of menstruation</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>5&#8239;mg 3 times a day, to be started 3 days before expected onset (menstruation occurs 2&#8211;3 days after stopping).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Breast cancer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;mg daily, increased if necessary to 60&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Short-term contraception</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>200&#8239;mg, to be administered within first 5 days of cycle or immediately after parturition (duration 8 weeks), then 200&#8239;mg after 8&#8239;weeks if required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Contraception</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Females of childbearing potential</p>\n<p>350&#8239;micrograms daily, dose to be taken at same time each day, starting on day 1 of cycle then continuously, if administration delayed for 3 hours or more it should be regarded as a &#8216;missed pill'.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63756\" outputclass=\"contraindications\" rev=\"1.40\" parent=\"/drugs/norethisterone\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<title>General contraindications:</title>\r\n<p>\r\n<ph outputclass=\"contraindication\">Avoid in patients with a history of liver tumours</ph>; <ph outputclass=\"contraindication\">breast cancer (unless progestogens are being used in the management of this condition)</ph>; <ph outputclass=\"contraindication\">genital cancer (unless progestogens are being used in the management of this condition)</ph>; <ph outputclass=\"contraindication\">history during pregnancy of idiopathic jaundice</ph>; <ph outputclass=\"contraindication\">history during pregnancy of pemphigoid gestationis (non-contraceptive indications)</ph>; <ph outputclass=\"contraindication\">history during pregnancy of severe pruritus (non-contraceptive indications)</ph>; <ph outputclass=\"contraindication\">when used as a contraceptive, history of breast cancer (can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable)</ph>\r\n</p>\r\n<sectiondiv outputclass=\"additionalContraindications\">\r\n<p outputclass=\"title\">Specific contraindications:</p>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With oral use</p>\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"contraindication\">severe arterial disease</ph>; <ph outputclass=\"contraindication\">undiagnosed vaginal bleeding</ph>\r\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP63777\" outputclass=\"cautions\" rev=\"1.42\" parent=\"/drugs/norethisterone\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<title>General cautions:</title>\n<p>\n<ph outputclass=\"caution\">Asthma</ph>; <ph outputclass=\"caution\">cardiac dysfunction</ph>; <ph outputclass=\"caution\">conditions that may worsen with fluid retention</ph>; <ph outputclass=\"caution\">diabetes (progestogens can decrease glucose tolerance&#8212;monitor patient closely)</ph>; <ph outputclass=\"caution\">epilepsy</ph>; <ph outputclass=\"caution\">history of depression</ph>; <ph outputclass=\"caution\">hypertension</ph>; <ph outputclass=\"caution\">migraine</ph>; <ph outputclass=\"caution\">susceptibility to thromboembolism (particular caution with high dose)</ph>\n</p>\n<sectiondiv outputclass=\"additionalCautions\">\n<p outputclass=\"title\">Specific cautions:</p>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithIndications\">\n<p outputclass=\"title\">When used for contraception</p>\n<p>\n<ph outputclass=\"caution\">active trophoblastic disease (until return to normal of urine- and plasma-gonadotrophin concentration)&#8212;seek specialist advice</ph>; <ph outputclass=\"caution\">arterial disease</ph>; <ph outputclass=\"caution\">functional ovarian cysts</ph>; <ph outputclass=\"caution\">history of jaundice in pregnancy</ph>; <ph outputclass=\"caution\">malabsorption syndromes</ph>; <ph outputclass=\"caution\">past ectopic pregnancy</ph>; <ph outputclass=\"caution\">sex-steroid dependent cancer</ph>; <ph outputclass=\"caution\">systemic lupus erythematosus with positive (or unknown) anti-phospholipid antibodies</ph>\n</p>\n<p>\n<ph outputclass=\"routesAndIndications\">with <ph outputclass=\"route\">intramuscular</ph> use for contraception</ph>\n<ph outputclass=\"caution\">disturbances of lipid metabolism</ph>; <ph outputclass=\"caution\">history during pregnancy of deterioration of otosclerosis</ph>; <ph outputclass=\"caution\">history during pregnancy of pruritus</ph>; <ph outputclass=\"caution\">possible risk of breast cancer</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Use as a contraceptive in co-morbidities</p>\n<p>The product literature advises caution in patients with history of thromboembolism, hypertension, diabetes mellitus and migraine; evidence for caution in these conditions is unsatisfactory.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Breast cancer risk with contraceptive use</p>\n<p>There is a small increase in the risk of having breast cancer diagnosed in women using, or who have recently used, a progestogen-only contraceptive pill; this relative risk may be due to an earlier diagnosis. The most important risk factor appears to be the age at which the contraceptive is stopped rather than the duration of use; the risk disappears gradually during the 10 years after stopping and there is no excess risk by 10 years. A possible small increase in the risk of breast cancer should be weighed against the benefits.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63653\" outputclass=\"interactions\" rev=\"1.25\" parent=\"/drugs/norethisterone\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (progestogens).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use</p>\n<p>Effectiveness of parenteral progestogen-only contraceptives is not affected by antibacterials that do not induce liver enzymes. The effectiveness of norethisterone intramuscular injection is not affected by enzyme-inducing drugs and may be continued as normal during courses of these drugs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63583\" outputclass=\"sideEffects\" rev=\"1.44\" parent=\"/drugs/norethisterone\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acne</ph>; <ph outputclass=\"sideEffect\">alopecia</ph>; <ph outputclass=\"sideEffect\">anaphylactoid reactions</ph>; <ph outputclass=\"sideEffect\">breast tenderness</ph>; <ph outputclass=\"sideEffect\">change in libido</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">disturbance of appetite</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">fluid retention</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hirsutism</ph>; <ph outputclass=\"sideEffect\">insomnia (non-contraceptive indications)</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">menstrual disturbances</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">premenstrual-like syndrome</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">skin reactions</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>; <ph outputclass=\"sideEffect\">weight change</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intramuscular use</p>\n<p>\n<ph outputclass=\"sideEffect\">injection-site reactions</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Cervical cancer</p>\n<p>Use of injectable progestogen-only contraceptives may be associated with a small increased risk of cervical cancer, similar to that seen with combined oral contraceptives (use of combined oral contraceptives for 5 years or longer is associated with a small increased risk of cervical cancer; the risk diminishes after stopping and disappears by about 10 years). The risk of cervical cancer with other progestogen-only contraceptives is not yet known.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63642\" outputclass=\"pregnancy\" parent=\"/drugs/norethisterone\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Masculinisation of female fetuses and other defects reported with non-contraceptive use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63785\" outputclass=\"breastFeeding\" parent=\"/drugs/norethisterone\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Progestogen-only contraceptives do not affect lactation.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Higher doses (used in malignant conditions) may suppress lactation and alter milk composition&#8212;use lowest effective dose.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use</p>\n<p>Withhold breast-feeding for neonates with severe or persistent jaundice requiring medical treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63712\" outputclass=\"hepaticImpairment\" parent=\"/drugs/norethisterone\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>When used as a contraceptive; caution in severe liver disease and recurrent cholestatic jaundice, avoid in liver tumour.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Avoid in non-contraceptive indications.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63613\" outputclass=\"renalImpairment\" parent=\"/drugs/norethisterone\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in non-contraceptive indications.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP63624\" outputclass=\"patientAndCarerAdvice\" rev=\"1.35\" parent=\"/drugs/norethisterone\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundMissedDoses\">\n<title>Missed doses</title>\n<sectiondiv>\n<p outputclass=\"title\">Missed oral contraceptive pill</p>\n<p>The following advice is recommended: &#8216;If you forget a pill, take it as soon as you remember and carry on with the next pill at the right time. If the pill was more than 3 hours overdue you are not protected. Continue normal pill-taking but you must also use another method, such as the condom, for the next 2 days.&#8217;</p>\n<p>The Faculty of Sexual and Reproductive Healthcare recommends emergency contraception if one or more progestogen-only contraceptive tablets are missed or taken more than 3 hours late and unprotected intercourse has occurred before 2 further tablets have been correctly taken.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p outputclass=\"title\">Diarrhoea and vomiting with oral contraceptives</p>\n<p>Vomiting and persistent, severe diarrhoea can interfere with the absorption of oral progestogen-only contraceptives. If vomiting occurs within 2 hours of taking an oral progestogen-only contraceptive, another pill should be taken as soon as possible. If a replacement pill is not taken within 3 hours of the normal time for taking the progestogen-only pill, or in cases of persistent vomiting or very severe diarrhoea, additional precautions should be used during illness and for 2 days after recovery.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Starting routine for oral contraceptives</p>\n<p>One tablet daily, on a continuous basis, starting on day 1 of cycle and taken at the same time each day (if delayed by longer than 3 hours contraceptive protection may be lost). Additional contraceptive precautions are not necessary when initiating treatment. </p>\n<p>Changing from a combined oral contraceptive: start on the day following completion of the combined oral contraceptive course without a break (or in the case of ED tablets omitting the inactive ones). </p>\n<p>After childbirth: oral progestogen-only contraceptives can be started up to and including day 21 postpartum without the need for additional contraceptive precautions. If started more than 21 days postpartum, additional contraceptive precautions are required for 2 days.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Contraceptives by injection</p>\n<p>Full counselling backed by <i>patient information leaflet</i> required before administration&#8212;likelihood of menstrual disturbance and the potential for a delay in return to full fertility. Delayed return of fertility and irregular cycles may occur after discontinuation of treatment but there is no evidence of permanent infertility.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4497-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/norethisterone\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75432\" title=\"Tablet\" namespace=\"/drugs/norethisterone/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP106979\" title=\"Solution for injection\" namespace=\"/drugs/norethisterone/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85598\" namespace=\"/drugs/estradiol-with-norethisterone\" title=\"ESTRADIOL WITH NORETHISTERONE\" count=\"1\" rel=\"backlink\">ESTRADIOL WITH NORETHISTERONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP94807\" namespace=\"/drugs/ethinylestradiol-with-norethisterone\" title=\"ETHINYLESTRADIOL WITH NORETHISTERONE\" count=\"1\" rel=\"backlink\">ETHINYLESTRADIOL WITH NORETHISTERONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP94810\" namespace=\"/drugs/mestranol-with-norethisterone\" title=\"MESTRANOL WITH NORETHISTERONE\" count=\"1\" rel=\"backlink\">MESTRANOL WITH NORETHISTERONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78143\" namespace=\"/treatment-summaries/contraceptives-interactions\" title=\"Contraceptives, interactions\" count=\"1\" rel=\"backlink\">Contraceptives, interactions</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78400\" namespace=\"/treatment-summaries/sex-hormones\" title=\"Sex hormones\" count=\"2\" rel=\"backlink\">Sex hormones</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_673\" namespace=\"/interactions/list-of-drug-interactions/progestogens/norethisterone\" title=\"Norethisterone\" count=\"1\" rel=\"link\">Norethisterone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75432\" namespace=\"/drugs/norethisterone/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP106979\" namespace=\"/drugs/norethisterone/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP4497",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/norethisterone",
    "basename": "norethisterone",
    "title": "NORETHISTERONE",
    "interactants": [
        {
            "id": "bnf_int_673",
            "label": "Norethisterone"
        }
    ],
    "vtmid": "13964211000001102",
    "drugClassification": [
        "Progestogens"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Endometriosis",
                        "html": "Endometriosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;15 mg daily for 4&#8211;6 months or longer, to be started on day 5 of cycle; increased to 20&#8211;25 mg daily if required, dose only increased if spotting occurs and reduced once bleeding has stopped.",
                        "html": "<p>10&#8211;15&#8239;mg daily for 4&#8211;6 months or longer, to be started on day 5 of cycle; increased to 20&#8211;25&#8239;mg daily if required, dose only increased if spotting occurs and reduced once bleeding has stopped.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Dysfunctional uterine bleeding (to arrest bleeding)",
                        "html": "Dysfunctional uterine bleeding (to arrest bleeding)"
                    },
                    {
                        "textContent": "Menorrhagia (to arrest bleeding)",
                        "html": "Menorrhagia (to arrest bleeding)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg 3 times a day for 10 days.",
                        "html": "<p>5&#8239;mg 3 times a day for 10 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Dysfunctional uterine bleeding (to prevent bleeding)",
                        "html": "Dysfunctional uterine bleeding (to prevent bleeding)"
                    },
                    {
                        "textContent": "Menorrhagia (to prevent bleeding)",
                        "html": "Menorrhagia (to prevent bleeding)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg twice daily, to be taken from day 19 to day 26 of cycle.",
                        "html": "<p>5&#8239;mg twice daily, to be taken from day 19 to day 26 of cycle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Dysmenorrhoea",
                        "html": "Dysmenorrhoea"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg 3 times a day for 3&#8211;4 cycles, to be taken from day 5&#8211;24 of cycle.",
                        "html": "<p>5&#8239;mg 3 times a day for 3&#8211;4 cycles, to be taken from day 5&#8211;24 of cycle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Premenstrual syndrome (but not recommended)",
                        "html": "Premenstrual syndrome (but not recommended)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg 2&#8211;3 times a day for several cycles, to be taken from day 19&#8211;26 of cycle.",
                        "html": "<p>5&#8239;mg 2&#8211;3 times a day for several cycles, to be taken from day 19&#8211;26 of cycle.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Postponement of menstruation",
                        "html": "Postponement of menstruation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg 3 times a day, to be started 3 days before expected onset (menstruation occurs 2&#8211;3 days after stopping).",
                        "html": "<p>5&#8239;mg 3 times a day, to be started 3 days before expected onset (menstruation occurs 2&#8211;3 days after stopping).</p>",
                        "ageGroup": "females of childbearing potential"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Breast cancer",
                        "html": "Breast cancer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "40 mg daily, increased if necessary to 60 mg daily.",
                        "html": "<p>40&#8239;mg daily, increased if necessary to 60&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Short-term contraception",
                        "html": "Short-term contraception"
                    }
                ],
                "specificity": {
                    "routes": [
                        "deep intramuscular injection"
                    ],
                    "textContent": "By deep intramuscular injection",
                    "html": "By deep intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "200 mg, to be administered within first 5 days of cycle or immediately after parturition (duration 8 weeks), then 200 mg after 8 weeks if required.",
                        "html": "<p>200&#8239;mg, to be administered within first 5 days of cycle or immediately after parturition (duration 8 weeks), then 200&#8239;mg after 8&#8239;weeks if required.</p>",
                        "ageGroup": "females of childbearing potential"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Contraception",
                        "html": "Contraception"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "350 micrograms daily, dose to be taken at same time each day, starting on day 1 of cycle then continuously, if administration delayed for 3 hours or more it should be regarded as a &#8216;missed pill'.",
                        "html": "<p>350&#8239;micrograms daily, dose to be taken at same time each day, starting on day 1 of cycle then continuously, if administration delayed for 3 hours or more it should be regarded as a &#8216;missed pill'.</p>",
                        "ageGroup": "females of childbearing potential"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Avoid in patients with a history of liver tumours",
                "html": "Avoid in patients with a history of liver tumours"
            },
            {
                "type": "contraindications",
                "textContent": "breast cancer (unless progestogens are being used in the management of this condition)",
                "html": "breast cancer (unless progestogens are being used in the management of this condition)"
            },
            {
                "type": "contraindications",
                "textContent": "genital cancer (unless progestogens are being used in the management of this condition)",
                "html": "genital cancer (unless progestogens are being used in the management of this condition)"
            },
            {
                "type": "contraindications",
                "textContent": "history during pregnancy of idiopathic jaundice",
                "html": "history during pregnancy of idiopathic jaundice"
            },
            {
                "type": "contraindications",
                "textContent": "history during pregnancy of pemphigoid gestationis (non-contraceptive indications)",
                "html": "history during pregnancy of pemphigoid gestationis (non-contraceptive indications)"
            },
            {
                "type": "contraindications",
                "textContent": "history during pregnancy of severe pruritus (non-contraceptive indications)",
                "html": "history during pregnancy of severe pruritus (non-contraceptive indications)"
            },
            {
                "type": "contraindications",
                "textContent": "when used as a contraceptive, history of breast cancer (can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable)",
                "html": "when used as a contraceptive, history of breast cancer (can be used after 5 years if no evidence of disease and non-hormonal contraceptive methods unacceptable)"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                },
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "severe arterial disease",
                "html": "severe arterial disease",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "undiagnosed vaginal bleeding",
                "html": "undiagnosed vaginal bleeding",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Asthma",
                "html": "Asthma"
            },
            {
                "type": "cautions",
                "textContent": "cardiac dysfunction",
                "html": "cardiac dysfunction"
            },
            {
                "type": "cautions",
                "textContent": "conditions that may worsen with fluid retention",
                "html": "conditions that may worsen with fluid retention"
            },
            {
                "type": "cautions",
                "textContent": "diabetes (progestogens can decrease glucose tolerance&#8212;monitor patient closely)",
                "html": "diabetes (progestogens can decrease glucose tolerance&#8212;monitor patient closely)"
            },
            {
                "type": "cautions",
                "textContent": "epilepsy",
                "html": "epilepsy"
            },
            {
                "type": "cautions",
                "textContent": "history of depression",
                "html": "history of depression"
            },
            {
                "type": "cautions",
                "textContent": "hypertension",
                "html": "hypertension"
            },
            {
                "type": "cautions",
                "textContent": "migraine",
                "html": "migraine"
            },
            {
                "type": "cautions",
                "textContent": "susceptibility to thromboembolism (particular caution with high dose)",
                "html": "susceptibility to thromboembolism (particular caution with high dose)"
            }
        ],
        "cautionsOrContraindicationsWithIndications": [
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "active trophoblastic disease (until return to normal of urine- and plasma-gonadotrophin concentration)&#8212;seek specialist advice",
                "html": "active trophoblastic disease (until return to normal of urine- and plasma-gonadotrophin concentration)&#8212;seek specialist advice",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "arterial disease",
                "html": "arterial disease",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "functional ovarian cysts",
                "html": "functional ovarian cysts",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "history of jaundice in pregnancy",
                "html": "history of jaundice in pregnancy",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "malabsorption syndromes",
                "html": "malabsorption syndromes",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "past ectopic pregnancy",
                "html": "past ectopic pregnancy",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "sex-steroid dependent cancer",
                "html": "sex-steroid dependent cancer",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "systemic lupus erythematosus with positive (or unknown) anti-phospholipid antibodies",
                "html": "systemic lupus erythematosus with positive (or unknown) anti-phospholipid antibodies",
                "specificity": {
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "disturbances of lipid metabolism",
                "html": "disturbances of lipid metabolism",
                "specificity": {
                    "routes": [
                        "intramuscular"
                    ],
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "history during pregnancy of deterioration of otosclerosis",
                "html": "history during pregnancy of deterioration of otosclerosis",
                "specificity": {
                    "routes": [
                        "intramuscular"
                    ],
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "history during pregnancy of pruritus",
                "html": "history during pregnancy of pruritus",
                "specificity": {
                    "routes": [
                        "intramuscular"
                    ],
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "possible risk of breast cancer",
                "html": "possible risk of breast cancer",
                "specificity": {
                    "routes": [
                        "intramuscular"
                    ],
                    "textContent": "When used for contraception",
                    "html": "When used for contraception",
                    "indications": [
                        "contraception"
                    ]
                }
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Use as a contraceptive in co-morbidities",
                "textContent": "The product literature advises caution in patients with history of thromboembolism, hypertension, diabetes mellitus and migraine; evidence for caution in these conditions is unsatisfactory.",
                "html": "<p>The product literature advises caution in patients with history of thromboembolism, hypertension, diabetes mellitus and migraine; evidence for caution in these conditions is unsatisfactory.</p>"
            },
            {
                "type": "importantAdvice",
                "title": "Breast cancer risk with contraceptive use",
                "textContent": "There is a small increase in the risk of having breast cancer diagnosed in women using, or who have recently used, a progestogen-only contraceptive pill; this relative risk may be due to an earlier diagnosis. The most important risk factor appears to be the age at which the contraceptive is stopped rather than the duration of use; the risk disappears gradually during the 10 years after stopping and there is no excess risk by 10 years. A possible small increase in the risk of breast cancer should be weighed against the benefits.",
                "html": "<p>There is a small increase in the risk of having breast cancer diagnosed in women using, or who have recently used, a progestogen-only contraceptive pill; this relative risk may be due to an earlier diagnosis. The most important risk factor appears to be the age at which the contraceptive is stopped rather than the duration of use; the risk disappears gradually during the 10 years after stopping and there is no excess risk by 10 years. A possible small increase in the risk of breast cancer should be weighed against the benefits.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (progestogens).",
                "html": "<p>Appendix 1 (progestogens).</p>"
            },
            {
                "type": "general",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use",
                    "routes": [
                        "intramuscular"
                    ]
                },
                "textContent": "Effectiveness of parenteral progestogen-only contraceptives is not affected by antibacterials that do not induce liver enzymes. The effectiveness of norethisterone intramuscular injection is not affected by enzyme-inducing drugs and may be continued as normal during courses of these drugs.",
                "html": "<p>Effectiveness of parenteral progestogen-only contraceptives is not affected by antibacterials that do not induce liver enzymes. The effectiveness of norethisterone intramuscular injection is not affected by enzyme-inducing drugs and may be continued as normal during courses of these drugs.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Acne",
                        "html": "Acne",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "alopecia",
                        "html": "alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anaphylactoid reactions",
                        "html": "anaphylactoid reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "breast tenderness",
                        "html": "breast tenderness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "change in libido",
                        "html": "change in libido",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "disturbance of appetite",
                        "html": "disturbance of appetite",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fluid retention",
                        "html": "fluid retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hirsutism",
                        "html": "hirsutism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "insomnia (non-contraceptive indications)",
                        "html": "insomnia (non-contraceptive indications)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "menstrual disturbances",
                        "html": "menstrual disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "premenstrual-like syndrome",
                        "html": "premenstrual-like syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "skin reactions",
                        "html": "skin reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "weight change",
                        "html": "weight change",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "injection-site reactions",
                        "html": "injection-site reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intramuscular use",
                            "html": "With intramuscular use",
                            "routes": [
                                "intramuscular"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Cervical cancer",
                "textContent": "Use of injectable progestogen-only contraceptives may be associated with a small increased risk of cervical cancer, similar to that seen with combined oral contraceptives (use of combined oral contraceptives for 5 years or longer is associated with a small increased risk of cervical cancer; the risk diminishes after stopping and disappears by about 10 years). The risk of cervical cancer with other progestogen-only contraceptives is not yet known.",
                "html": "<p>Use of injectable progestogen-only contraceptives may be associated with a small increased risk of cervical cancer, similar to that seen with combined oral contraceptives (use of combined oral contraceptives for 5 years or longer is associated with a small increased risk of cervical cancer; the risk diminishes after stopping and disappears by about 10 years). The risk of cervical cancer with other progestogen-only contraceptives is not yet known.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Masculinisation of female fetuses and other defects reported with non-contraceptive use.",
                "html": "<p>Masculinisation of female fetuses and other defects reported with non-contraceptive use.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Progestogen-only contraceptives do not affect lactation.",
                "html": "<p>Progestogen-only contraceptives do not affect lactation.</p>"
            },
            {
                "type": "generalInformation",
                "textContent": "Higher doses (used in malignant conditions) may suppress lactation and alter milk composition&#8212;use lowest effective dose.",
                "html": "<p>Higher doses (used in malignant conditions) may suppress lactation and alter milk composition&#8212;use lowest effective dose.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intramuscular use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use",
                    "routes": [
                        "intramuscular"
                    ]
                },
                "textContent": "Withhold breast-feeding for neonates with severe or persistent jaundice requiring medical treatment.",
                "html": "<p>Withhold breast-feeding for neonates with severe or persistent jaundice requiring medical treatment.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "When used as a contraceptive; caution in severe liver disease and recurrent cholestatic jaundice, avoid in liver tumour.",
                "html": "<p>When used as a contraceptive; caution in severe liver disease and recurrent cholestatic jaundice, avoid in liver tumour.</p>"
            },
            {
                "type": "generalInformation",
                "textContent": "Avoid in non-contraceptive indications.",
                "html": "<p>Avoid in non-contraceptive indications.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in non-contraceptive indications.",
                "html": "<p>Use with caution in non-contraceptive indications.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundMissedDoses": [
            {
                "type": "adviceAroundMissedDoses",
                "title": "Missed oral contraceptive pill",
                "textContent": "The following advice is recommended: &#8216;If you forget a pill, take it as soon as you remember and carry on with the next pill at the right time. If the pill was more than 3 hours overdue you are not protected. Continue normal pill-taking but you must also use another method, such as the condom, for the next 2 days.&#8217;\n\nThe Faculty of Sexual and Reproductive Healthcare recommends emergency contraception if one or more progestogen-only contraceptive tablets are missed or taken more than 3 hours late and unprotected intercourse has occurred before 2 further tablets have been correctly taken.",
                "html": "<p>The following advice is recommended: &#8216;If you forget a pill, take it as soon as you remember and carry on with the next pill at the right time. If the pill was more than 3 hours overdue you are not protected. Continue normal pill-taking but you must also use another method, such as the condom, for the next 2 days.&#8217;</p><p>The Faculty of Sexual and Reproductive Healthcare recommends emergency contraception if one or more progestogen-only contraceptive tablets are missed or taken more than 3 hours late and unprotected intercourse has occurred before 2 further tablets have been correctly taken.</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Diarrhoea and vomiting with oral contraceptives",
                "textContent": "Vomiting and persistent, severe diarrhoea can interfere with the absorption of oral progestogen-only contraceptives. If vomiting occurs within 2 hours of taking an oral progestogen-only contraceptive, another pill should be taken as soon as possible. If a replacement pill is not taken within 3 hours of the normal time for taking the progestogen-only pill, or in cases of persistent vomiting or very severe diarrhoea, additional precautions should be used during illness and for 2 days after recovery.",
                "html": "<p>Vomiting and persistent, severe diarrhoea can interfere with the absorption of oral progestogen-only contraceptives. If vomiting occurs within 2 hours of taking an oral progestogen-only contraceptive, another pill should be taken as soon as possible. If a replacement pill is not taken within 3 hours of the normal time for taking the progestogen-only pill, or in cases of persistent vomiting or very severe diarrhoea, additional precautions should be used during illness and for 2 days after recovery.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "title": "Starting routine for oral contraceptives",
                "textContent": "One tablet daily, on a continuous basis, starting on day 1 of cycle and taken at the same time each day (if delayed by longer than 3 hours contraceptive protection may be lost). Additional contraceptive precautions are not necessary when initiating treatment.\n\nChanging from a combined oral contraceptive: start on the day following completion of the combined oral contraceptive course without a break (or in the case of ED tablets omitting the inactive ones).\n\nAfter childbirth: oral progestogen-only contraceptives can be started up to and including day 21 postpartum without the need for additional contraceptive precautions. If started more than 21 days postpartum, additional contraceptive precautions are required for 2 days.",
                "html": "<p>One tablet daily, on a continuous basis, starting on day 1 of cycle and taken at the same time each day (if delayed by longer than 3 hours contraceptive protection may be lost). Additional contraceptive precautions are not necessary when initiating treatment. </p><p>Changing from a combined oral contraceptive: start on the day following completion of the combined oral contraceptive course without a break (or in the case of ED tablets omitting the inactive ones). </p><p>After childbirth: oral progestogen-only contraceptives can be started up to and including day 21 postpartum without the need for additional contraceptive precautions. If started more than 21 days postpartum, additional contraceptive precautions are required for 2 days.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "title": "Contraceptives by injection",
                "textContent": "Full counselling backed by patient information leaflet required before administration&#8212;likelihood of menstrual disturbance and the potential for a delay in return to full fertility. Delayed return of fertility and irregular cycles may occur after discontinuation of treatment but there is no evidence of permanent infertility.",
                "html": "<p>Full counselling backed by <i>patient information leaflet</i> required before administration&#8212;likelihood of menstrual disturbance and the potential for a delay in return to full fertility. Delayed return of fertility and irregular cycles may occur after discontinuation of treatment but there is no evidence of permanent infertility.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75432",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP106979",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85598",
                "label": "ESTRADIOL WITH NORETHISTERONE",
                "type": "drug"
            },
            {
                "id": "PHP94807",
                "label": "ETHINYLESTRADIOL WITH NORETHISTERONE",
                "type": "drug"
            },
            {
                "id": "PHP94810",
                "label": "MESTRANOL WITH NORETHISTERONE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78143",
                "label": "Contraceptives, interactions",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78400",
                "label": "Sex hormones",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_673",
                "label": "Norethisterone",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75432",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP106979",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}